Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

In Russia, over 57,000 new cases of malignant tumors of the trachea, bronchi, and lung were diagnosed in 2009, accounting for 19,8% of all cancers in men and 3,9% of all cancers in women. For most patients in Russia, these cancers are detected at a late stage (stage III – 32,4% and stage IV – 36,0%)...

Full description

Bibliographic Details
Main Authors: O I Kit, L Yu Vladimirova, E A Sholokhova
Format: Article
Language:Russian
Published: IP Habib O.N. 2013-03-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/view/26881
_version_ 1818339606369665024
author O I Kit
L Yu Vladimirova
E A Sholokhova
author_facet O I Kit
L Yu Vladimirova
E A Sholokhova
author_sort O I Kit
collection DOAJ
description In Russia, over 57,000 new cases of malignant tumors of the trachea, bronchi, and lung were diagnosed in 2009, accounting for 19,8% of all cancers in men and 3,9% of all cancers in women. For most patients in Russia, these cancers are detected at a late stage (stage III – 32,4% and stage IV – 36,0%). Administration of maintenance therapy is one strategy to prolong response or the length of stable disease, resulting in improved survival for patients whose disease has not progressed after first-line induction therapy. This review will summarize the results of phase 3 studies of pemetrexed as maintenance therapy in advanced non-small cell lung cancer.
first_indexed 2024-12-13T15:29:41Z
format Article
id doaj.art-49b44f9bdd6d46038bb37898306d4707
institution Directory Open Access Journal
issn 1815-1434
1815-1442
language Russian
last_indexed 2024-12-13T15:29:41Z
publishDate 2013-03-01
publisher IP Habib O.N.
record_format Article
series Современная онкология
spelling doaj.art-49b44f9bdd6d46038bb37898306d47072022-12-21T23:40:13ZrusIP Habib O.N.Современная онкология1815-14341815-14422013-03-01151273124101Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studiesO I KitL Yu VladimirovaE A SholokhovaIn Russia, over 57,000 new cases of malignant tumors of the trachea, bronchi, and lung were diagnosed in 2009, accounting for 19,8% of all cancers in men and 3,9% of all cancers in women. For most patients in Russia, these cancers are detected at a late stage (stage III – 32,4% and stage IV – 36,0%). Administration of maintenance therapy is one strategy to prolong response or the length of stable disease, resulting in improved survival for patients whose disease has not progressed after first-line induction therapy. This review will summarize the results of phase 3 studies of pemetrexed as maintenance therapy in advanced non-small cell lung cancer.https://modernonco.orscience.ru/1815-1434/article/view/26881non-small cell lung cancernonsquamous non-small cell lung cancermaintenance therapypemetrexed
spellingShingle O I Kit
L Yu Vladimirova
E A Sholokhova
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Современная онкология
non-small cell lung cancer
nonsquamous non-small cell lung cancer
maintenance therapy
pemetrexed
title Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
title_full Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
title_fullStr Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
title_full_unstemmed Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
title_short Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
title_sort efficacy and safety of pemetrexed maintenance therapy in advanced non small cell lung cancer a review of phase iii studies
topic non-small cell lung cancer
nonsquamous non-small cell lung cancer
maintenance therapy
pemetrexed
url https://modernonco.orscience.ru/1815-1434/article/view/26881
work_keys_str_mv AT oikit efficacyandsafetyofpemetrexedmaintenancetherapyinadvancednonsmallcelllungcancerareviewofphaseiiistudies
AT lyuvladimirova efficacyandsafetyofpemetrexedmaintenancetherapyinadvancednonsmallcelllungcancerareviewofphaseiiistudies
AT easholokhova efficacyandsafetyofpemetrexedmaintenancetherapyinadvancednonsmallcelllungcancerareviewofphaseiiistudies